Editas Medicine

Editas Medicine
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Gene Editing
CRISPR Technology
Genomic Medicine
Clinical Research
Rare Diseases
Editas Medicine在招职位
0个在招职位
目前没有在招职位
已关闭职位
1个职位
Join Our Team
Remote
已关闭 1个月前
产品与服务

reni-cel
Gene Therapy
ED
EDIT-101
Gene Therapy
ED
EDIT-301
Cell Therapy
CR
CRISPR Gene Editing Platform
Technology Platform
ED
EDIT-201
Gene Therapy

In Vivo Gene Editing Medicines
Gene Therapy
ED
EDIT-103
Gene Therapy
IN
In Vivo Gene Editing Services
R&D Services
CR
CRISPR/Cas Gene Editing Platform
Platform Technology
EX
Ex Vivo Cell Engineering
R&D Services
EX
Ex Vivo Gene Editing Services
Research Services
EN
Engineered Natural Killer (eNK) Cell Platform
Cell Therapy
ED
EDIT-401
Gene Therapy
领导团队
CS
Charlene Stern
Executive Vice President & General Counsel
KB
Kevin Bitterman
Interim President
DRL
David R. Liu
Founder
FZ
Feng Zhang
Founder
相似公司

Gilead Sciences
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.
Foster City, San Mateo County
10,001+人
Public
估值 $85B
234个在招职位
VI
Vir Biotechnology
Immunology-focused biotech
San Francisco, California
201-500人
Public
估值 $1.2B
11个在招职位

Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases.
Thousand Oaks, Ventura County
10,001+人
Public
估值 $138B
1,634个在招职位

Bio-Rad
Global leader in life science research and clinical diagnostics
Hercules, Contra Costa County
5,001-10,000人
Public
估值 $3.2B

Mammoth Biosciences
Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, our company’s ultracompact systems are…
Brisbane, San Mateo County
51-200人
Private
估值 $800M
最新动态
All
X
News
HN
YouTube
Editas Medicine Eyes First Human Trial for CRISPR Cholesterol Therapy EDIT-401 - Yahoo Finance
Yahoo Finance
News
·
今天
Editas Medicine, Inc. SEC Filing (Sep 9, 2026) - Stock Titan
Stock Titan
News
·
今天
Editas Medicine at Wells Fargo conference: a focused bet on CRISPR - Investing.com Canada
Investing.com Canada
News
·
今天
Editas Medicine Appoints Dan Ory as Chief Medical Officer - citybiz
citybiz
News
·
昨天
Editas Medicine names Dan Ory as chief medical officer - Investing.com
Investing.com
News
·
昨天
更多 (剩余15条)
浏览量
2
申请点击
0
模拟申请
0
收藏
0
评价
4.2
5条评价
工作生活平衡
4.0
薪酬
3.5
企业文化
4.3
职业发展
2.8
管理层
3.5
78%
推荐率
优点
Supportive and collaborative team environment
Great work-life balance and flexible hours
Cutting-edge research opportunities
缺点
Limited career advancement opportunities
High expectations and stress levels
Disorganized management practices
薪资范围
38个数据点
Director
1份报告
-
年薪总额
基本工资
$150,000
股票
-
联系方式与地址